FDA.reportPublic FDA data

atazanavir 300 MG / cobicistat 150 MG Oral Tablet

RxCUI
1601654
RxNorm name
atazanavir 300 MG / cobicistat 150 MG Oral Tablet
Display name
atazanavir 300 MG / cobicistat 150 MG Oral Tablet
Full name
atazanavir 300 MG / cobicistat 150 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:06

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EVOTAZATAZANAVIR AND COBICISTATE.R. Squibb & Sons, L.L.C.83db29d7-5d85-49d6-8cb6-740473365cf82025-05-12Warnings, Adverse reactionsExact identifier
rxcui: 1601654

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
83db29d7-5d85-49d6-8cb6-740473365cf8atazanavir 300 MG / cobicistat 150 MG Oral Tablet [PSN] · atazanavir 300 MG / cobicistat 150 MG Oral Tablet [SCD]216These highlights do not include all the information needed to use EVOTAZ safely and effectively. See full prescribing information for EVOTAZ. EVOTAZ ® (atazanavir and cobicistat) tablet, for oral use Initial U.S. Approval: 201520250512